beta Catenin (CTNNB1) pTyr654 (incl. pos. control) Mouse Monoclonal Antibody [Clone ID: 1B11]
CAT#: AM00016BT-N
beta Catenin (CTNNB1) pTyr654 (incl. pos. control) mouse monoclonal antibody, clone 1B11, Biotin
Conjugation: Unconjugated
Need it in bulk or conjugated?
Get a free quote
CNY 6,798.00
货期*
5周
规格
Product images
Specifications
Product Data | |
Clone Name | 1B11 |
Applications | WB |
Recommend Dilution | Western Blot. Recommended blocking buffer: Casein/Tween 20 based blocking and blot incubation buffer. |
Reactivity | Canine, Human, Mouse |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Synthetic phosphopeptide conjugated to KLH. |
Specificity | This antibody specifically recognizes β-catenin phosphorylated at tyrosine 654 at 90 kDa and gamma-catenin at 70 kDa. Due to sequence homologies of the phospho-epitope surrounding pY 654 there may be crossreactions with other proteins (e.g. Annexin A11 at 56 kDa, gamma-catenin at 70 kDa, Desmoplakin at 81 kDa, TNFalpha-induced protein 2 at 73 kDa, Ribosomal protein S6 kinase alpha 6 at 90 kDa). |
Formulation | PBS/0.09% Na-Azide/PEG and Sucrose Label: Biotin State: Liquid purified IgG |
Concentration | lot specific |
Purification | Size exclusion chromatography |
Conjugation | Biotin |
Storage Condition | Store the antibody (aliquote in liquid nitrogen) at -80°C. Avoid repeated freezing and thawing. Thaw aliquots at 37°C. Thawed aliquots may be stored at 4°C up to 3 months. |
Gene Name | catenin beta 1 |
Database Link | |
Background | The α-, β- and γ-catenins are cytoplasmic proteins mediating the interaction of Ca2+-dependent transmembrane adhesion molecules (cadherins) with the cytoskeletal network. Additionally, β-catenin is a substrate of both receptor and non-receptor tyrosine kinases. Tyrosine 86 and tyrosine 654 are substrates of EGF receptor and src family kinases while tyrosine 142 is a substrate of fer tyrosine kinases. |
Synonyms | CTNNB1, CTNNB, Beta-catenin |
Reference Data |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...